Effect of catecholestrogen administration during adriamycin-induced cardiomyopathy in ovariectomized rat

Free Radical Research

Volumn 39, Issue 9, 2005, Pages 943-948

  Munoz Castaneda J R ^a   Tunez I ^a   Munoz M C ^a   Bujalance, I ^a   Muntane J ^b   Montilla, P ^a  

^a Facultad de Medicina de Córdoba   (Spain)

^b HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

Author keywords

Adriamycin; Cardiomyopathy; Catecholestrogens; Ovariectomy; Oxidative stress

Indexed keywords

2 HYDROXYESTRADIOL; 4 HYDROXYESTRADIOL; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CATALASE; CATECHOL ESTROGEN; CREATINE KINASE; DOXORUBICIN; GLUTATHIONE; GLUTATHIONE PEROXIDASE; LACTATE DEHYDROGENASE; LIPID PEROXIDE; NITRIC OXIDE; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CARBONYLATION; CARDIOMYOPATHY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG MECHANISM; ENZYME ACTIVITY; FEMALE; LIPID PEROXIDATION; MEAN ARTERIAL PRESSURE; NONHUMAN; OVARIECTOMY; OXIDATIVE STRESS; RAT; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

ALANINE TRANSAMINASE; ANIMALS; CARDIOMYOPATHIES; CATALASE; CREATINE KINASE; DOXORUBICIN; ESTRADIOL; ESTROGENS, CATECHOL; FEMALE; GLUTATHIONE PEROXIDASE; HEMODYNAMIC PROCESSES; L-LACTATE DEHYDROGENASE; OVARIECTOMY; OXIDATIVE STRESS; RATS; RATS, WISTAR; SUPEROXIDE DISMUTASE;

EID: 24144440979     PISSN: 10715762     EISSN: None     Source Type: Journal    
DOI: 10.1080/10715760400013805     Document Type: Article

References (31)

1. Jellink PH, Michnovicz IJ, Bradlow HL. Influence of indole-3-carbinol on the hepatic microsomal formation catechol estrogens. Steroids 1991;56:446-450.
2. Emons G, Merriam GR, Pfeiffer D, Loriaux DL, Ball P, Knuppen R. Metabolism of exogenous 4- and 2-hydroxyestradiol in the human male. J Steroid Biochem 1987;28:499-504.
3. Dubey RK, Jackson EK. Cardiovascular protective effects of 17 β estradiol metabolites. J Appl Physiol 2001;91:1868-1883.
4. Ruiz-Larrea MB, Martín C, Martínez R, Navarro R, Lacort M, Miller NJ. Antioxidant activities of estrogens against aqueous and lipophilic radicals; differences between phenol and catecholestrogens. Chem Phys Lipids 2000;105: 179-188.
5. Lacort M, Leal AM, Liza M, Martín C, Martínez R, Ruiz-Larrea MB. Protective effect of estrogen and catecholestrogen against peroxidative membrane damage in vitro. Lipids 1995; 30(2):141-146.
6. Markides CSA, Roy D, Liehr JG. Concentration dependence of pro-oxidant and antioxidant properties of catecholestrogens. Arch Biochem Biophys 1998;360(1):105-112.
7. Ruiz-Larrea MB, Leal AM, Martin C, Martinez R, Lacort M. Effects of estrogens on the redox chemistry of iron: A possible mechanism of the antioxidant action of estrogens. Steroids 1995;60(11):780-783.
8. Nakano M, Sugioka K, Naito I, Takekoshi S, Niki E. Novel and potent biological antioxidants on membrane phospholipid peroxidation: 2-Hydroxyestrone and 2-hydroxyestradiol. Biochem Biophys Res Commun 1987;142:919-924.
9. Teepker M, Anthes N, Krieg JC, Vedder H. 2-OH-estradiol, an endogenous hormone with neuroprotective functions. J Psychiatr Res 2003;37:517-523.
10. Muraoka S, Miura T. Protection by estrogens of biological damage by 2, 2′-azobis (2-aminopropane) dihydrochloride. J Steroid Biochem Mol Biol 2002;82:343-348.
11. Brown JW, Kesler CT, Neary T, Fishman LM. Effects of androgens and estrogens and catechol and methoxy-estrogen derivatives on mitogen-activated protein kinase (ERK(1,2)) activity in SW-13 human adrenal carcinoma cells. Horm Metab Res 2001;33(3):127-130.
12. Zacharia LC, Jackson EK, Gillespie DG, Dubey RK. Catecholamines abrogate antimitogenic effects of 2-hydroxyestradiol on human aortic vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2001;21:1745-1750.
13. Liehr JG. Dual role of oestrogens as hormones and procarcinogens tumour initiation by metabolic activation of oestrogens. Eur J Cancer Preven 1997;6(1):3-10.
14. Thibodeau PA, Paquette B. DNA damage induced by catecholestrogens in the presence of copper (II: Generation of reactive oxygen species and enhacement by NADH. Free Rad Biol Med 1999;11-12:1367-1377.
15. Adjei AA, Weinshilboum RM. Catecholestrogen sulfatation: Possible role in carcinogenesis. Biochem Biophys Res Commun 2002;292:402-408.
16. Gewirtz DA. Critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin. Biochem Pharmacol 1999;57:727-741.
17. Quiles JL, Huertas JR, Battino M, Mataix J, Ramírez-Tortosa MC. Antioxidant nutrients and adriamycin toxicity. Toxicology 2002;180:79-95.
18. Singal PK, Li T, Kumar D, Danelisen I, Iliskovic N. Adriamycin-induced heart-failure: Mechanism and modulation. Mol Cell Biochem 2000;207:77-85.
19. Poumeau-Delille, G. Techniques biologiques en endocrinologie experimentale chez rat. Masson and Cie 1953.
20. Montilla P, Tünez I, Muñoz MC, Delgado MJ, Salcedo M. Hyperlipidemic nephropathic induced by adriamycin in ovariectomized rats: Role of free radicals and effects of 17 β estradiol administration. Nephron 2000;85:65-70.
21. Oliver CN, Ahn BW, Moerman EJ, Goldstein S, Stadtman ER. Age-related changes in oxidized proteins. J Biol Chem 1987;262:5488-5491.
22. Flohé L, Gunzler WA. Assays of glutathione peroxidase. Methods Enzymol 1984;105:114-121.
23. Aebi H. Catalase in vitro. Methods Enzymol 1984;105: 121-126.
24. Sun Y, Oberley LW, Li Y. A simple method for clinical assay of superoxide dismutase. Clin Chem 1988;34:479-500.
25. Komura S, Nagata N, Ohishi N, Yagi K. Protective effect of catecholestrogen on lipid hydroperoxide-induced injury to culture bovine aortic endothelial cells and on lipid peroxidation of low-density lipoprotein. J Clin Biochem Nut 1995;19:71-77.
26. Miura T, Muraoka S, Ogiso T. Inhibition of lipid peroxidation by estradiol and 2-hydroxyestradiol. Steroids 1996; 61(6):379-383.
27. Tang M, Abplanalp W, Ayres S, Subbiah MTR. Superior and distinct antioxidant effects of selected estrogen metabolites on lipid peroxidation. Metabolism 1966;45:411-414.
28. Leal AM, Ruiz-Larrea MB, Martínez R, Lacort M. Cytoprotective actions of estrogens against ter-butyl hidroperoxide- induced toxicity in hepatocytes. Biochem Pharmacol 1998;56:1463-1469.
29. Martín C, Barturen K, Martínez R, Lacort M, Ruiz-Larrea MB. In vitro inhibition by estrogen of the oxidative modifications of human lipoproteins. Physiol Biochem 1998;54:195-202.
30. Mobley JA, Bhat AS, Brueggemeier RW. Measurement of oxidative DNA damage by catecholestrogens and analogues in vitro. Chem Res Toxicol 1999;12(3):270-277.
31. Martínez R, Quintana K, Navarro R, Martín C, Hernández ML, Aurrekoetxea I, Ruiz-Sanz JI, Lacort M, Ruiz-Larrea MB. Pro-oxidant and antioxidant potential of catecholestrogens against ferrylmyoglobin-induced oxidative stress. Biochim Biophys Acta 2002;1583(2):167-175.